<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
(Rule 13d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(a)
AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(a)
Amendment No. 2*
Angeion Corporation
--------------------------------------------
(Name of Company)
Common Stock, par value $.01 per share
--------------------------------------------
(Title of Class of Securities)
03462H 10 7
--------------------------------------------
(CUSIP Number)
James C. Colihan, Esq.
Coudert Brothers
1114 Avenue of the Americas
New York, NY 10036 (212) 626-4400
--------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
October 15, 1998
--------------------------------------------
(Date of Event which Requires Filing
of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box |_|.
Note: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule 13d-1(a) for other parties to whom copies are to be
sent.
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter disclosure
provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
Page 2 of 11 Pages
CUSIP No. 03462H 10 7 13D
- --------------------------------------------------------------------------------
1 Name of Reporting Person Synthelabo
S.S. or I.R.S. Identification No. of Above Person 000-00-0000
- --------------------------------------------------------------------------------
2 Check the Appropriate Box If a Member of a Group*
a. /__/
b. /__/
- --------------------------------------------------------------------------------
3 SEC Use Only
- --------------------------------------------------------------------------------
4 Source of Funds*
00(1)
- --------------------------------------------------------------------------------
5 Check If Disclosure of Legal Proceedings Is Required Pursuant to
Items 2(d) or 2(e) /__/
- --------------------------------------------------------------------------------
6 Citizenship or Place of Organization
France
- --------------------------------------------------------------------------------
7 Sole Voting Power
Number of 11,935,935
Shares
Beneficially 8 Shared Voting Power
Owned By 0
Each
Reporting 9 Sole Dispositive Power
Person 11,935,935
With
10 Shared Dispositive Power
0
- --------------------------------------------------------------------------------
11 Aggregate Amount Beneficially Owned by Each Reporting Person
11,935,935
- --------------------------------------------------------------------------------
12 Check Box If the Aggregate Amount in Row (11) Excludes Certain
Shares* /__/
- --------------------------------------------------------------------------------
13 Percent of Class Represented By Amount in Row (11)
21.8%
- --------------------------------------------------------------------------------
- --------
(1) The Supplemental Shares and Supplemental Warrants have been issued in this
transaction without consideration in accordance with the Investment Agreement,
as described in Item 4.
<PAGE>
Page 3 of 11 Pages
14 Type of Reporting Person
CO
- --------------------------------------------------------------------------------
* SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
Page 4 of 11 Pages
This Amendment No. 2 (this "Amendment") to the Schedule 13D filed on December
19, 1997 (the "Schedule 13D") on behalf of Synthelabo, a societe anonyme
organized under the laws of France ("Synthelabo"), relates to the Common Stock,
par value $.01 per share ("Common Stock"), of Angeion Corporation, a Minnesota
corporation (the "Issuer"), and is being filed pursuant to Rule 13d-2 under the
Securities Exchange Act of 1934, as amended (the "Exchange Act"). Capitalized
terms used but not otherwise defined herein shall have the meanings ascribed to
such terms in the Schedule 13D.
Item 1. Security and Company.
This Amendment relates to the Common Stock of the Issuer. The address
of the principal executive offices of the Issuer is 7601 Northland
Drive, Brooklyn Park, MN 55428.
Item 2. Identity and Background.
Schedule A to the Schedule 13D, attached hereto, has been modified to
reflect current information.
Item 3. Source and Amount of Funds or Other Consideration.
This Amendment relates to the acquisition (the "Acquisition") as of
October 15, 1998 by Synthelabo of (i) 3,846,153 additional shares of
Common Stock of the Issuer (the "Supplemental Shares"), and (ii) a
Common Stock Purchase Warrant (the "Supplemental Warrant") entitling
Synthelabo to acquire an additional 2,307,692 shares of Common Stock of
the Issuer pursuant to the Amended and Restated Investment and Master
Strategic Relationship Agreement, dated as of October 9, 1997, between
the Issuer and Synthelabo (the "Investment Agreement"). The
Supplemental Shares and Supplemental Warrants were issued without
consideration as an adjustment to Synthelabo's initial investment
pursuant to the Investment Agreement.
Item 4. Purpose of Transaction.
Pursuant to the Investment Agreement, Synthelabo acquired the
Supplemental Shares and the Supplemental Warrant as an adjustment to
the 2,251,408 shares of the Issuer's Common Stock (the "Initial
Shares") and Common Stock Purchase Warrant (the "Warrant") initially
acquired by Synthelabo on December 9, 1997. The Warrant entitled
Synthelabo to purchase an additional 1,350,845 shares of the Issuer's
Common Stock pursuant to the Investment Agreement. The Supplemental
Shares were calculated in accordance with the Investment Agreement by
dividing $15,000,000 by $2.46, representing a 30% premium over the
average quoted price of the Common Stock for all trading days within
the fifteen (15) trading days immediately prior to and including
October 9, 1998, and subtracting therefrom the number of Initial
Shares. The Supplemental Warrant is immediately exerciseable at an
exercise price of $2.46 per share and has an expiration date of
December 9, 2001. Synthelabo may sell all or a portion of its shares of
Issuer Common Stock in open-market or private transactions, depending
upon prevailing market conditions or other factors, each in accordance
with and subject to the terms of the Investment Agreement and
applicable securities laws. Pursuant to the Investment Agreement,
Synthelabo has the right to designate one nominee to serve upon
appointment or election to the Board of Directors.
<PAGE>
Page 5 of 11 Pages
The Reporting Person continues to have no plans or proposals which
relate to or would result in any of the events, actions or conditions
specified in paragraphs (a) through (j) of the instructions to Item 4
or any similar action or effect. Nothing in this statement on Schedule
13D shall be deemed to preclude the Reporting Person from developing or
implementing any such plan or proposal.
Item 5. Interest in Securities of the Company.
(a) Following the Acquisition, Synthelabo will be the direct owner of
7,459,959 shares of the Issuer's Common Stock, together with warrants
to purchase a further 4,475,976 shares of the Issuer's Common Stock.
Accordingly, based upon information contained in the Issuer's quarterly
report on Form 10-Q for the period ended September 30, 1998 and filed
on October 15, 1998, as well as information obtained from the Issuer.
Synthelabo will be the direct owner of 19.4% of the issued and
outstanding shares of the Issuer's Common Stock as a result of the
7,459,959 shares owned by Synthelabo (21.8% of such issued and
outstanding shares of the Issuer's Common Stock as a result of such
shares and the 4,475,976 shares underlying the warrants).
(b) Synthelabo has sole power to vote and dispose of all of the shares
beneficially owned by it as reported above.
(c) Synthelabo acquired the Supplemental Shares and the Supplemental
Warrants as of October 15, 1998 in a privately negotiated transaction.
(d) Not applicable.
(e) Not applicable.
<PAGE>
Page 6 of 11 Pages
SIGNATURE
After reasonable inquiry and to the best of their respective knowledge
and belief, the undersigned certify that the information set forth in this
statement is true, complete and correct.
Dated: October 27, 1998
SYNTHELABO
By: /s/ Herve Guerin
Name: Herve Guerin
Title: President du Conseil d'Administration
<PAGE>
Page 7 of 11 Pages
SCHEDULE A
1. DIRECTORS AND EXECUTIVE OFFICERS OF SYNTHELABO
<TABLE>
<CAPTION>
Name and Principal Present Principal
Business Address; Position with Employment if not
Citizenship Synthelabo Stated at Left
<S> <C> <C>
Herve Guerin President
17 avenue de Madrid du Conseil
92200 Neuilly sur Seine, de l'Administration
France
Citizenship: French
Pierre Castres Saint-Martin Administrateur et Directeur General
11 rue Porto Riche Vice-President Adjoint de L'Oreal;
92190 Meudon, France Vice-President de L'Oreal
Citizenship: French
Jacques Baetz Administrateur
57 rue de Plaisance
92250 La Garenne-Colombes,
France
Citizenship: French
Regis Dufour Administrateur
32 chemin de la Foret
78860 Saint Nom la Breteche,
France
Citizenship: French
Pierre Meneau Administrateur Gerant de G.D.I.E.
1 Allee des Sequoias
Corene Montfleury
18700 La Tronche, France
Citizenship: French
Yves Faivre Administrateur
88 rue la Fontaine
75016 Paris, France
Citizenship: French
</TABLE>
<PAGE>
Page 8 of 11 Pages
<TABLE>
<S> <C> <C>
Pierre Lepienne Administrateur
Le Moulin du Patis Vice-President Executif
02570 Chezy sur Marne,
France
Citizenship:
Carlos Pomaret Administrateur Administrateur de l'Action
Le Petit Heurteloup Sociale Pharmaceutique
Longnes
78980 Breval, France
Citizenship: French
Gerard Chouraqui Administrateur
58 boulevard du General
Leclerc
92200 Neuilly sur Seine,
France
Citizenship: French
Salomon Zender Langer Administrateur
92 rue Jouffroy d'Abbans
75017 Paris, France
Citizenship: French
</TABLE>
2. DIRECTORS AND EXECUTIVE OFFICERS OF L'OREAL
<TABLE>
<CAPTION>
Name and Principal Present Principal
Business Address; Position with Employment if not
Citizenship L'Oreal Stated at Left
<S> <C> <C>
Lindsay Owen-Jones President du Conseil
16 rue Royale d'Administration
75008 Paris, France
Citizenship: UK
Pierre Castres Saint Martin Administrateur et
14 rue Royale Directeur General
75008 Paris, France Adjoint;
Citizenship: French Vice-President
</TABLE>
<PAGE>
Page 9 of 11 Pages
<TABLE>
<S> <C> <C>
Francois Dalle Administrateur President de l'Institut
Villa Clairefontaine International de l'Entreprise;
14 chemin du Nant d'Argent President de l'Association
CH-1223 Cologny, Switzerland Entreprise et Progres
Citizenship: French
Guy Landon Administrateur President de Artcurial SA
14 rue Royale
75008 Paris, France
Citizenship: French
Marc Ladreit de Lacharriere Administrateur President de Fimalac SA
7 rue Boissonnade
75004 Paris, France
Citizenship: French
Olivier Lecerf Administrateur Administrateur et President
8 rue Guy de Maupassant d'Honneur de Lafarge SA
75116 Paris, France
Citizenship: French
Oswald Helmut Maucher Administrateur et President de Nestle SA Suisse
9 chemin de la Fin Vice-President
1802 Corseaux Canton de
Vaud, Switzerland
Citizenship: German
Jean-Pierre Mayers Administrateur Administrateur de Gesparal
3 Rond Point Saint James et Vice-President et de Nestle SA Suisse
92200 Neuilly sur Seine,
France
Citizenship: French
Jacques P. Visiox Administrateur
8 avenue Leon Heuzey
75016 Paris, France
Citizenship: French
Liliane Bettencourt Administrateur Business Woman
18 rue de Labordere Vice-President de Gesparal
9220 Neuilly sur Seine,
France
Citizenship: French
</TABLE>
<PAGE>
Page 10 of 11 Pages
<TABLE>
<S> <C> <C>
Edouard de Royere Administrateur Administrateur de Air Liquide
4 rue de Chanaleilles SA
75007 Paris, France
Citizenship: French
Francoise Bettencourt-Mayers Administrateur Administrateur de Gesparal SA
5 rue du 8 mai 1945
92110 Clichy, France
Citizenship: French
Peter Brabeck-Letmathe Administrateur Administrateur Delegue de
55 avenue Nestle Nestle SA Suisse;
CH-1800 Vevey, Switzerland Administrateur de Gesparal
Citizenship: Austrian
Francisco Castander Blasco Administrateur
55 avenue Nestle
CH-1800 Vevey, Switzerland
Citizenship: Spanish
</TABLE>
3. DIRECTORS AND EXECUTIVE OFFICERS OF GESPARAL
<TABLE>
<CAPTION>
Name and Principal Present Principal
Business Address; Position with Employment if not
Citizenship Gesparal Stated at Left
<S> <C> <C>
Andre Bettencourt President du Conseil
18 rue de Labordere d'Administration
92200 Neuilly sur Seine,
France
Citizenship: French
Francois Dalle Administrateur President de l'Institut
Villa Clairefontaine et Vice-President International de l'Entreprise;
14 chemin du Nant d'Argent President de l'Association
CH-1223 Cologny, Switzerland Entreprise et Progres
Citizenship: French
Oswald Helmut Maucher Administrateur President de Nestle SA
9 chemin de la Fin et Vice-President Suisse
1802 Canton de
Vaud, Switzerland
Citizenship: German
</TABLE>
<PAGE>
Page 11 of 11 Pages
<TABLE>
<S> <C> <C>
Jose Daniel Gubert Administrateur
Chemin de Plantaz, 65
CH-1095 Lutry
Switzerland
Citizenship: Spanish
Liliane Bettencourt Vice-President et Business Woman
18 rue de Labordere Administrateur
92200 Neuilly sur Seine,
France
Citizenship: French
Francoise Bettencourt-Mayers Administrateur Administrateur de Gesparal SA
5 rue du 8 mai 1945
92110 Clichy, France
Citizenship: French
Jean-Pierre Mayers Administrateur Administrateur de Gesparal
3 Rond Point Saint James et Vice-President et Nestle SA Suisse
92200 Neuilly sur Seine,
France
Citizenship: French
Lindsay Owen-Jones President du Conseil
16 rue Royale d'Administration
75008 Paris, France
Citizenship: UK
Peter Brabeck-Letmathe Administrateur Administrateur Delegue de
55 avenue Nestle Nestle SA Suisse
CH-1800 Vevey, Switzerland
Citizenship: Austrian
Francisco Castaner Blasco Administrateur
55 avenue Nestle
CH-1800 Vevey, Switzerland
Citizenship: Spanish
</TABLE>
